2Pi Optics launches world's first metalens fisheye camera

At CES 20204, 2Pi Optics launched the first fisheye camera utilizing the company's innovative metalens technology, marking a significant advancement in the tech industry. This pioneering technology is highly anticipated by electronics design engineers and product managers seeking to shrink the size of digital cameras in applications such as advanced driver-assistance systems (ADAS), AR/VR, UAVs, robotics, and various industrial settings.

 

"Today's refractive fisheye lenses, which are used to capture wide-angle, panoramic images, have hit a design roadblock," said Dr. Juejun Hu, president and co-founder of 2Pi Optics. "They require between six and twelve stacked lens components, which limits their compactness and affordability. Our design, in contrast, outperforms conventional refractive, wide-FOV optics in all areas: size, weight, performance, and cost. Better still, 2Pi's metalenses can be manufactured at wafer scale in conventional semiconductor foundries."

 

WHY METALENSES?

  • In contrast to conventional wide-FOV refractive lenses, which are typically made up of multiple stacked lens pieces, 2Pi’s proprietary technology uses a wafer-thin, flat metalens (a wafer-thin material patterned with microscopic features that focus and manipulate lightwaves) to replace the bulky and expensive lenses. 

  • Through this revolutionary approach, ultracompact, high-performance optical imagers and sensors can be designed, resulting in revolutionary applications in consumer electronics, automotive sensing, industrial inspection, and biomedical diagnosis.

  • Size, weight, performance, and cost are all advantages of 2Pi over conventional refractive, wide-FOV optics. 

  • In contrast to conventional lenses, 2Pi's metalenses can be manufactured inexpensively in conventional semiconductor foundries.

 

MEDIA OUTREACH TO SECURE ENGAGEMENT

  • The company's core value proposition was refined well in advance of CES2024, one of the world's busiest technology events.

  • Phased media outreach started in December 2023 to alert dozens of journalists attending CES to the upcoming announcement.

  • Several on-booth meetings and interviews were also secured in addition to the numerous media stories.

 

MEDIA COVERAGE

Previous
Previous

rBIO biosimilar insulin advances to clinical trials — strategy by ZingPR

Next
Next

CureLab's DNA vaccine prolongs the life of platinum-resistant ovarian cancer patients